EGFR and gestational diabetes: Furthermore, miRNAs such as miR-27a, miR-137, miR-92a, miR-33a, miR-30d, miR-362-5p, and miR-502-5p were downregulated in women with GDM, and they are known to target the epidermal growth factor receptor/Class I phosphoinositide—3 kinases (EGFR/PI3K/Akt) pathway, which sheds light on the potential mechanisms underlying GDM and the associated risk of macrosomia [95].